C108H134Cl2N20O17S2 — CID 167636573
tert-butyl 4-[2-[2-(1H-benzimidazol-2-yl)-5-(3-methylsulfonylphenyl)-3-oxo-1H-pyrazol-4-yl]ethyl]piperidine-1-carboxylate;tert-butyl 4-[2-[2-(1H-benzimidazol-2-yl)-5-(4-methylsulfonylphenyl)-3-oxo-1H-pyrazol-4-yl]ethyl]piperidine-1-carboxylate;2-(6-chloro-1H-benzimidazol-2-yl)-5-cyclopropyl-4-[2-[1-(2-hydroxy-2-methylpropanoyl)piperidin-4-yl]ethyl]-1H-pyrazol-3-one;propan-2-yl 4-[2-(6-chloro-1H-benzimidazol-2-yl)-4-[2-(oxan-4-yl)ethyl]-3-oxo-1H-pyrazol-5-yl]piperidine-1-carboxylate (PubChem CID 167636573) has the molecular formula C108H134Cl2N20O17S2 and a molecular weight of 2119.42 g/mol. Its IUPAC name is tert-butyl 4-[2-[2-(1H-benzimidazol-2-yl)-5-(3-methylsulfonylphenyl)-3-oxo-1H-pyrazol-4-yl]ethyl]piperidine-1-carboxylate;tert-butyl 4-[2-[2-(1H-benzimidazol-2-yl)-5-(4-methylsulfonylphenyl)-3-oxo-1H-pyrazol-4-yl]ethyl]piperidine-1-carboxylate;2-(6-chloro-1H-benzimidazol-2-yl)-5-cyclopropyl-4-[2-[1-(2-hydroxy-2-methylpropanoyl)piperidin-4-yl]ethyl]-1H-pyrazol-3-one;propan-2-yl 4-[2-(6-chloro-1H-benzimidazol-2-yl)-4-[2-(oxan-4-yl)ethyl]-3-oxo-1H-pyrazol-5-yl]piperidine-1-carboxylate.
| Compound Name | tert-butyl 4-[2-[2-(1H-benzimidazol-2-yl)-5-(3-methylsulfonylphenyl)-3-oxo-1H-pyrazol-4-yl]ethyl]piperidine-1-carboxylate;tert-butyl 4-[2-[2-(1H-benzimidazol-2-yl)-5-(4-methylsulfonylphenyl)-3-oxo-1H-pyrazol-4-yl]ethyl]piperidine-1-carboxylate;2-(6-chloro-1H-benzimidazol-2-yl)-5-cyclopropyl-4-[2-[1-(2-hydroxy-2-methylpropanoyl)piperidin-4-yl]ethyl]-1H-pyrazol-3-one;propan-2-yl 4-[2-(6-chloro-1H-benzimidazol-2-yl)-4-[2-(oxan-4-yl)ethyl]-3-oxo-1H-pyrazol-5-yl]piperidine-1-carboxylate |
|---|---|
| PubChem CID | 167636573 |
| Molecular Formula | C108H134Cl2N20O17S2 |
| Molecular Weight | 2119.42 g/mol |
| Exact Mass | 2116.91 |
| IUPAC Name | tert-butyl 4-[2-[2-(1H-benzimidazol-2-yl)-5-(3-methylsulfonylphenyl)-3-oxo-1H-pyrazol-4-yl]ethyl]piperidine-1-carboxylate;tert-butyl 4-[2-[2-(1H-benzimidazol-2-yl)-5-(4-methylsulfonylphenyl)-3-oxo-1H-pyrazol-4-yl]ethyl]piperidine-1-carboxylate;2-(6-chloro-1H-benzimidazol-2-yl)-5-cyclopropyl-4-[2-[1-(2-hydroxy-2-methylpropanoyl)piperidin-4-yl]ethyl]-1H-pyrazol-3-one;propan-2-yl 4-[2-(6-chloro-1H-benzimidazol-2-yl)-4-[2-(oxan-4-yl)ethyl]-3-oxo-1H-pyrazol-5-yl]piperidine-1-carboxylate |
| SMILES | CC(C)(C)OC(=O)N1CCC(CCc2c(-c3ccc(S(C)(=O)=O)cc3)[nH]n(-c3nc4ccccc4[nH]3)c2=O)CC1.CC(C)(C)OC(=O)N1CCC(CCc2c(-c3cccc(S(C)(=O)=O)c3)[nH]n(-c3nc4ccccc4[nH]3)c2=O)CC1.CC(C)(O)C(=O)N1CCC(CCc2c(C3CC3)[nH]n(-c3nc4ccc(Cl)cc4[nH]3)c2=O)CC1.CC(C)OC(=O)N1CCC(c2[nH]n(-c3nc4ccc(Cl)cc4[nH]3)c(=O)c2CCC2CCOCC2)CC1 |
| InChI | InChI=1S/2C29H35N5O5S.C26H34ClN5O4.C24H30ClN5O3/c1-29(2,3)39-28(36)33-16-14-19(15-17-33)12-13-22-25(20-8-7-9-21(18-20)40(4,37)38)32-34(26(22)35)27-30-23-10-5-6-11-24(23)31-27;1-29(2,3)39-28(36)33-17-15-19(16-18-33)9-14-22-25(20-10-12-21(13-11-20)40(4,37)38)32-34(26(22)35)27-30-23-7-5-6-8-24(23)31-27;1-16(2)36-26(34)31-11-7-18(8-12-31)23-20(5-3-17-9-13-35-14-10-17)24(33)32(30-23)25-28-21-6-4-19(27)15-22(21)29-25;1-24(2,33)22(32)29-11-9-14(10-12-29)3-7-17-20(15-4-5-15)28-30(21(17)31)23-26-18-8-6-16(25)13-19(18)27-23/h5-11,18-19,32H,12-17H2,1-4H3,(H,30,31);5-8,10-13,19,32H,9,14-18H2,1-4H3,(H,30,31);4,6,15-18,30H,3,5,7-14H2,1-2H3,(H,28,29);6,8,13-15,28,33H,3-5,7,9-12H2,1-2H3,(H,26,27) |
| InChIKey | YICRUUVWYCJVQM-UHFFFAOYSA-N |
| XLogP | 17.68 |
| TPSA | 472.55 Ų |
| H-Bond Donors | 9 |
| H-Bond Acceptors | 25 |
| Rotatable Bonds | 24 |
| Heavy Atoms | 149 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2119.42 |
| LogP ≤ 5 | 17.68 |
| H-Bond Donors ≤ 5 | 9 |
| H-Bond Acceptors ≤ 10 | 25 |
| Structural Alerts | {'alert_name': '>_2_ester_groups', 'substructure': 'N/A'} |
|---|